Patents by Inventor Justin Schwab
Justin Schwab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220152317Abstract: Skin can be treated by piercing skin with a plurality of needles of an injection device and ejecting a dose of fluid therethrough. The device can include a housing, a plunger disposed in the housing, a cartridge disposed in the housing, and one or more dosing chambers. The plurality of needles can be coupled to the housing and be in fluid communication with the cartridge. Advancement of the plunger can cause a dose of fluid to be ejected from the plurality of needles.Type: ApplicationFiled: November 29, 2021Publication date: May 19, 2022Inventors: Ethan FRANKLIN, Dimitrios STROUMPOULIS, Zachary DOMINGUEZ, Justin SCHWAB, Bastien MANDAROUX, Edwin KAYDA
-
Patent number: 11185641Abstract: Skin can be treated by piercing skin with a plurality of needles of an injection device and ejecting a dose of fluid therethrough. The device can include a housing, a plunger disposed in the housing, a cartridge disposed in the housing, and one or more dosing chambers. The plurality of needles can be coupled to the housing and be in fluid communication with the cartridge. Advancement of the plunger can cause a dose of fluid to be ejected from the plurality of needles.Type: GrantFiled: March 11, 2019Date of Patent: November 30, 2021Assignee: ALLERGAN, INC.Inventors: Ethan Franklin, Dimitrios Stroumpoulis, Zachary Dominguez, Justin Schwab, Bastien Mandaroux, Edwin Kayda
-
Publication number: 20210307947Abstract: An implantable device used in a gastric band system includes an access port, a tube coupled to the access port, and a shielding device covering a portion of the tube. The shielding device is positioned adjacent to the access port and covers the end of the tube coupled to the access port. The shielding device is made from a puncture resistant material, to protect the tube from puncture by a misplaced syringe needle inserted by a physician.Type: ApplicationFiled: August 21, 2013Publication date: October 7, 2021Applicant: Allergan, Inc.Inventors: Ethan Franklin, Justin Schwab
-
Publication number: 20190358566Abstract: Lipoaspirate can be treated for use in fat grafting procedures. For example, the lipoaspirate can be placed in a container having an inlet for receiving the lipoaspirate and an outlet for dispensing and removal of desired materials from the lipoaspirate. The inlet and the outlet can be located on a common side of first and second filter elements. An activation mechanism can be actuated to move the first filter element relative to the second filter element within the container to separate cellular components of the lipoaspirate from non-cellular components of the lipoaspirate.Type: ApplicationFiled: August 5, 2019Publication date: November 28, 2019Inventors: Zachary DOMINGUEZ, Justin SCHWAB, Tiago BERTOLOTE, Jason METZNER, Ethan FRANKLIN
-
Publication number: 20190247583Abstract: Described herein are syringe accessories that can be attached to standard syringes. These accessories utilize one or more mechanisms that can provide at least one additional sensory feedback to the user when performing an aliquot or dosed injection. In other embodiments, the accessories can prevent overdosing.Type: ApplicationFiled: April 22, 2019Publication date: August 15, 2019Inventors: Justin Schwab, Edwin J. Kada, Zachary Dominguez, Christopher Mudd
-
Patent number: 10369500Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: GrantFiled: February 1, 2016Date of Patent: August 6, 2019Assignee: Allergan, Inc.Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
-
Publication number: 20190201635Abstract: Skin can be treated by piercing skin with a plurality of needles of an injection device and ejecting a dose of fluid therethrough. The device can include a housing, a plunger disposed in the housing, a cartridge disposed in the housing, and one or more dosing chambers. The plurality of needles can be coupled to the housing and be in fluid communication with the cartridge. Advancement of the plunger can cause a dose of fluid to be ejected from the plurality of needles.Type: ApplicationFiled: March 11, 2019Publication date: July 4, 2019Inventors: Ethan FRANKLIN, Dimitrios STROUMPOULIS, Zachary DOMINGUEZ, Justin SCHWAB, Bastien MANDAROUX, Edwin KAYDA
-
Patent number: 10226585Abstract: Injection devices are provided which include a handpiece capable of housing a cartridge containing an injectable composition, and a head coupled to the handpiece and housing a plurality of retractable needles and a dosing mechanism. Methods of treating skin surfaces are also provided.Type: GrantFiled: September 14, 2015Date of Patent: March 12, 2019Assignee: Allergan, Inc.Inventors: Ethan Franklin, Dimitrios Stroumpoulis, Zachary Dominguez, Justin Schwab, Bastien Mandaroux, Edwin Kayda
-
Publication number: 20190070215Abstract: Methods and devices for use in reducing the appearance of dimpled skin or other undesirable appearance of skin in a cellulitic region of a patient are provided. The methods include the steps of disrupting fibrous septae located beneath the skin of a cellulitic region and introducing a composition beneath the skin, the composition being effective to reduce or prevent regrowth of the fibrous septae.Type: ApplicationFiled: November 5, 2018Publication date: March 7, 2019Inventors: Tracy Ann Perry, Rui Avelar, Justin Schwab, Zachary Dominguez, Edwin Kayda
-
Patent number: 10117892Abstract: Methods and devices for use in reducing the appearance of dimpled skin or other undesirable appearance of skin in a cellulitic region of a patient are provided. The methods include the steps of disrupting fibrous septae located beneath the skin of a cellulitic region and introducing a composition beneath the skin, the composition being effective to reduce or prevent regrowth of the fibrous septae.Type: GrantFiled: August 29, 2014Date of Patent: November 6, 2018Assignee: Allergan, Inc.Inventors: Tracy Ann Perry, Rui Avelar, Justin Schwab, Zachary Dominguez, Edwin Kayda
-
Publication number: 20180133401Abstract: Described are devices, systems, and methods for processing adipose tissue for reintroduction into a body. In some embodiments, adipose tissue is mixed with an additive prior to reintroduction.Type: ApplicationFiled: January 11, 2018Publication date: May 17, 2018Inventors: Justin SCHWAB, Mike AUGARTEN, Darin MESSINA, Jason METZNER, Ethan FRANKLIN
-
Patent number: 9895247Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Also, certain devices slow gastric emptying by blocking or otherwise impeding flow through the pyloric sphincter. A number of devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: GrantFiled: April 6, 2015Date of Patent: February 20, 2018Assignee: Apollo Endosurgery US, Inc.Inventors: Mitchell H. Babkes, Zachary P. Dominguez, Justin Schwab
-
Patent number: 9895246Abstract: Transoral implantable devices includes an inflatable body made of a material that permits it to be compressed into a substantially linear transoral delivery configuration and that when implanted in the stomach is adapted to reduce obesity or weight by stimulating the stomach walls of the patient. The body has a plurality of popout features on its surface that reside generally flush with the inflatable body in relaxed, refracted states, and which respond to an increase in pressure within the inflatable body by projecting outward from the body in a stressed, deployed state. The popout features may convert between their retracted and deployed states by movement of rolling diaphragms formed in the inflatable body.Type: GrantFiled: February 12, 2015Date of Patent: February 20, 2018Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Justin Schwab, Mitchell H. Babkes
-
Patent number: 9867939Abstract: Described are devices, systems, and methods for processing adipose tissue for reintroduction into a body. In some embodiments, adipose tissue is mixed with an additive prior to reintroduction.Type: GrantFiled: March 11, 2014Date of Patent: January 16, 2018Assignee: Allergan, Inc.Inventors: Justin Schwab, Mike Augarten, Darin Messina, Jason Metzner, Ethan Franklin
-
Patent number: 9681974Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: GrantFiled: October 21, 2014Date of Patent: June 20, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Mitchell H. Babkes, Justin Schwab, Christopher S. Mudd, Jason Metzner
-
Patent number: 9655757Abstract: Generally described herein are apparatus, systems and methods related to a novel esophageal device implantable in the patient's body and designed to replicate the restrictive and satiety mechanism associated with gastric banding systems known in the art. The device can be a compliant and tubular-shaped and fixated within the gastro-esophageal lumen using tissue anchors.Type: GrantFiled: October 5, 2015Date of Patent: May 23, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Justin Schwab, Zachary Dominguez, Jason Metzner
-
Publication number: 20160144302Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: ApplicationFiled: February 1, 2016Publication date: May 26, 2016Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
-
Publication number: 20160095984Abstract: Injection devices are provided which include a handpiece capable of housing a cartridge containing an injectable composition, and a head coupled to the handpiece and housing a plurality of retractable needles and a dosing mechanism. Methods of treating skin surfaces are also provided.Type: ApplicationFiled: September 14, 2015Publication date: April 7, 2016Inventors: Ethan Franklin, Dimitrios Stroumpoulis, Zachary Dominguez, Justin Schwab, Bastien Mandaroux, Edwin Kayda
-
Patent number: 9248384Abstract: Methods and devices for treating lipoaspirate for use in fat grafting procedures are provided and generally include a canister for containing lipoaspirate, a separation mechanism structured to separate both oils and other materials from cellular components of lipoaspirate contained in the canister. The separation mechanism includes filters having different filtering capacities, for example, different pore sizes.Type: GrantFiled: October 2, 2013Date of Patent: February 2, 2016Assignee: Allergan, Inc.Inventors: Zachary Dominguez, Justin Schwab, Tiago Bertolote, Jason Metzner, Ethan Franklin
-
Publication number: 20160022460Abstract: Generally described herein are apparatus, systems and methods related to a novel esophageal device implantable in the patient's body and designed to replicate the restrictive and satiety mechanism associated with gastric banding systems known in the art. The device can be a compliant and tubular-shaped and fixated within the gastro-esophageal lumen using tissue anchors.Type: ApplicationFiled: October 5, 2015Publication date: January 28, 2016Applicant: Apollo Endosurgery, Inc.Inventors: Justin Schwab, Zachary Dominguez, Jason Hoover